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Abstract
Background: Successful reprogramming of a somatic genome to produce a healthy clone by
somatic cells nuclear transfer (SCNT) is a rare event and the mechanisms involved in this process
are poorly defined. When serial or successive rounds of cloning are performed, blastocyst and full
term development rates decline even further with the increasing rounds of cloning. Identifying the
"cumulative errors" could reveal the epigenetic reprogramming blocks in animal cloning.
Results: Bovine clones from up to four generations of successive cloning were produced by
chromatin transfer (CT). Using Affymetrix bovine microarrays we determined that the
transcriptomes of blastocysts derived from the first and the fourth rounds of cloning (CT1 and CT4
respectively) have undergone an extensive reprogramming and were more similar to blastocysts
derived from in vitro fertilization (IVF) than to the donor cells used for the first and the fourth
rounds of chromatin transfer (DC1 and DC4 respectively). However a set of transcripts in the
cloned embryos showed a misregulated pattern when compared to IVF embryos. Among the genes
consistently upregulated in both CT groups compared to the IVF embryos were genes involved in
regulation of cytoskeleton and cell shape. Among the genes consistently upregulated in IVF
embryos compared to both CT groups were genes involved in chromatin remodelling and stress
coping.
Conclusion: The present study provides a data set that could contribute in our understanding of
epigenetic errors in somatic cell chromatin transfer. Identifying "cumulative errors" after serial
cloning could reveal some of the epigenetic reprogramming blocks shedding light on the
reprogramming process, important for both basic and applied research.

Background
The process of early embryonic development is determined by activation of the embryonic genome, which for
bovine embryos begins as a "minor genome activation" at

the 1-cell stage [1] ascending to a "major genome activation" during the 8-cell to 16-cell stage [2]. In the absence
of proper genome activation, the developing embryo will
die because it can no longer support its essential developPage 1 of 23
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mental functions [3,4]. In the case of embryos produced
by somatic cell nuclear transfer (SCNT) the somatic
nucleus has to be reprogrammed in order to restart and
continue the developmental process. It is believed that,
guided by the ooplasm, the somatic nucleus aborts its
own program of somatic gene expression and re-establishes a particular program of embryonic gene expression
necessary for normal embryo development [4].
Embryos produced by SCNT have lower developmental
rates than their in vitro and in vivo produced counterparts
[5]. Embryos produced by SCNT also have a greater incidence of apoptosis and consequently a lower number of
cells [6]. Additionally, SCNT derived embryos have
greater rates of embryo and fetal mortality, stillbirths and
perinatal deaths, which bring down the overall efficiency
of cloning. These alterations may be caused, at least partially, by incomplete epigenetic reprogramming of the
somatic nuclei [5,7]. Somatic cell chromatin transfer
(SCCT) attempts to facilitate the reprogramming process
by exposing the somatic cells, prior to the transfer, to a
mitotic cell extract, which is supposed to induce chromosome condensation and promote the removal and solubilisation of nuclear factors, enhancing nuclear remodelling
[8]. Compared with nuclear transfer, SCCT shows greater
survival of cloned calves up to at least 1 month and could
be a useful tool in understanding the mechanisms of
reprogramming [8]. Remarkably, a recent study did not
detect any significant differences in the global gene
expression profiles of SCCT and SCNT embryos [9].
Embryos derived from nuclear transfer have an abnormal
pattern of DNA methylation, in some cases resembling
that of somatic cells [10-12]. This aberrant DNA methylation pattern has been inversely correlated with the developmental potential of the cloned embryos [13].
Treatment of donor cells with DNA demethylation agents,
prior the nuclear transfer, may remove epigenetic marks
improving the ability of the somatic cells to be fully reprogrammed by the recipient karyoplast [14]. Global alteration of gene expression has been another finding in
embryos produced by cloning. The abnormal expression
of genes playing important roles in early embryonic development, implantation and fetal development is of particular interest. Conversely, other studies have reported a
significant reprogramming for SCNT embryos by the blastocyst stage and similar transcriptome profiles to those of
embryos produced in vitro or in vivo, suggesting that
defects in gene expression for SCNT embryos may occur
later during redifferentiation and organogenesis [15,16].
Among the abnormally expressed genes reported in
bovine cloned embryos are IL6, FGF4, and FGFr2 [17];
FGF4, DNMT1, Mash2, HSP70, and interferon tau [18];
Acrogranin, Cdx2, and ERR2 [19]. Cytokeratin 19, Cytok-
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eratin 8, Vimentin, Hsp27, Nidogen2 and MHC-I [20];
HDAC-1, 2, and 3, DNMT3A, and OCT4 [21]. Lower levels of transcripts involved in the retinoic acid signalling
pathway (RARB, CRAB1, HLA-A, THBS2, and SERPINB5)
were reported for cloned bovine embryos [22]. There have
been conflicting results when it comes to the expression of
particular genes in SCNT and IVF embryos. Such is the
case of the developmentally important POU5F1 gene,
which has been reported as misregulated in cloned
embryos compared to IVF derived blastocysts in some
studies [21,23], while being detected at similar concentration in others [17,24].
SCNT is often used for the production of human proteins
in the milk of transgenic animals. For the achievement of
some specific transgenic phenotypes, multiple genetic
modifications need to be completed through sequential
modifications in primary cells prior to nuclear transfer
[25]. Since transfection and selection of transgenic cells
requires nearly the entire lifespan of a cell, only one
genetic modification can be completed in each cell
lifespan [26]. Therefore, consecutive rounds of cloning
(also referred to "repeated cloning", "serial cloning",
"recloning" or "nuclear recycling") are performed. It has
been proposed that consecutive rounds of cloning, allow
for rejuvenation and selection of transformed cultured
cells [27-30] and that it may improve the efficiency of
SCNT by increasing the reprogramming potential of the
somatic cells [31,32]. Conversely, other reports suggest
that epigenetic errors could accumulate in the embryos as
a result of serial cloning and prolonged in vitro culture
decreasing cloning efficiency. After serial cloning up to the
sixth generation was performed in mice, no signs of telomere shortening or premature ageing were observed.
However, cloning efficiency significantly decreased with
increasing rounds of cloning [33]. A greatly reduced in
vitro and in vivo developmental capacity was reported for
bovine embryos derived after several rounds of serial cloning [34,35]. It has been suggested that extended culture
associated with transfection and selection procedures may
induce changes of somatic cells, which decrease the efficiency of nuclear transfer and that these changes cannot
be reversed by recloning [36].
The objective of the present study was to identify the
"cumulative errors" on global gene expression, caused by
serial rounds of chromatin transfer, by comparing the
transcriptome profile of IVF derived blastocysts to that of
SCCT derived blastocysts from the first and fourth rounds
of cloning (CT1 and CT4) using oligonucleotide microarray analysis (Affymetrix Bovine GeneChips). Donor cells
used for first and fourth rounds of cloning (DC1 and
DC4) were also the target of the study as we compared the
global gene expression of the SCCT embryos with their
respective donor cells. Additionally, we analyzed the
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expression patterns of a panel of selected genes, in fetal
fibroblasts obtained from foetuses from zero to fifth
rounds of chromatin transfer. Our results show that a substantial reprogramming has taken place in the cloned
embryos from both generations of chromatin transfer.
However, there was a set of differential expressed genes in
both groups of cloned embryos compared to their IVF
counterparts. The number and functions of these genes
could suggest accumulative misregulations probably
caused by the successive rounds of cloning.

Results
Isolation of RNA
On average 12.2 ng of total RNA were isolated from pools
of 3 embryos (between 3.2 and 4.5 ng per blastocyst). The
RNA integrity ranged from 1.8 to 1.96, based on the ratio
between the 28S and 18S ribosomal RNA bands from the
Bioanalyzer gel-like image (Figure 1).

Ladder

DC1-1

DC1-2

DC4-1

DC4-2

Transcriptome analyses
The Affymetrix GeneChip® Bovine Genome Array contains
24,129 probe sets representing over 23,998 bovine transcripts, including assemblies from approximately 19,000
UniGene Clusters. In order to assess the influence of the
two cycles of linear amplification, on the representation
of original transcripts, we compared microarray experiments from one-cycle and two-cycle amplifications using
total RNA from DC1. The results showed that amplification of messages using 1 vs. 2 cycles were highly consistent
with a correlation coefficient of 0.93 (data not shown).
These data confirm the manufacturer's results using 1 and
2 cycles of linear amplification.

Microarray experiments were performed in three biological replicates for all blastocysts (CT1, CT4 and IVF) and
donor cells (DC1 and DC4). Images were processed with
GCOS and data extracted using MAS 5.0. However, one of
the CT1 blastocyst chips did not pass the quality control
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Figure bioanalyzer
Agilent
1
gel-like image of total RNA
Agilent bioanalyzer gel-like image of total RNA. The image shows a total RNA gel like-image produced by the Bioanalyzer. (Ten out of the 15 samples used in the microarray experiment are shown since no more than 11 samples can be run at
one time). Lane L: Size markers. Lanes 1 and 2: total RNA from 106 donor cells used for the first round of embryonic cloning.
Lanes 3 and 4: total RNA from 106 donor cell used for the fourth round of cloning. Lanes 5 and 6: total RNA from a pool of 3
In Vitro Produced embryos. Lanes 7 and 8: total RNA from a pool of 3 embryos produced by the first round of chromatin
transfer. Lanes 9 and 10: total RNA from a pool of 3 embryos produced by the fourth round of chromatin transfer. The 28S
and 18s distinctive ribosomal RNA bands are observed for all samples.
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analysis [37] and was excluded from the study. The analyses for CT1 are based on the remaining two chips in this
group, which showed an appropriate p-value distribution.
The GCOS software expression data report showed that
56% of the probe sets were called "Present" (P) for all
donor cell chips. This number was lower for all blastocyst
chips with 44%, 41%, and 47% for IVF, CT1, and CT4
respectively. Probe sets that were called "Absent" (A) in all
the samples were excluded from the analysis. Therefore
only 16,521 probe sets were included in the analysis.
Hierarchical clustering classified all donor cells chips in
one single group indicating small differences in their gene
expression profiles. All blastocysts were classified in 2 distinctive clusters with IVF blastocysts in one group and all
cloned blastocysts in other group (Figure 2).
In pairwise comparisons among transcripts with a p-value
< 0.01, a False Discovery Rate (FDR) of 20%, and a Fold
Change >2.0 were considered differentially expressed. The
numbers of differentially expressed transcripts in all pairwise comparisons are presented in Table 1. The number of
probe sets that were differentially expressed between all 3
groups of blastocysts was significantly lower compared to
the number of differentially expressed transcripts between
donor cells and embryos (P < 0.01). This numeric difference indicates that a substantial reprogramming has
occurred in cloned blastocysts from both first and fourth
rounds of cloning. However there were significantly less
differentially expressed transcripts between cloned
embryos and donor cells than between IVF blastocysts
and donor cells (P < 0.01). Out of 83 differentially
expressed transcripts between both cell lines, 79 corresponded to absent or marginal signals, leaving only 4 differentially expressed transcripts. Chemokine binding
protein 2 (CCBP2) and myocilin, trabecular meshwork
inducible glucocorticoid response (MYOC) were upregulated in DC1 compared to DC4. Similar to hemicentin
(LOC528634) and similar to dolichyl pyrophosphate
phosphatase 1 (LOC504908) were the genes upregulated
in DC4 compared to DC1.
Because the bovine genome has not been fully annotated,
the annotation information available from NetAffx Analysis Center (Affymetrix) classifies probe sets as: 1) fully
annotated bovine genes; 2) transcripts similar to specific
genes, but not confirmed; 3) hypothetical proteins based
on sequence similarity; 4) cDNA clones; and 5) transcripts
with strong, moderate or weak similarity to genes from
other species. Table 2 presents a breakdown of the differentially expressed transcripts according to these categories. Only transcripts corresponding to annotated bovine
genes were included in further analyses.
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Multiple comparisons through one-way analysis of variance (ANOVA) using a Least Significant Differences (LSD)
test showed a set of 109 genes that were differentially
expressed in the cloned embryos and donor cells compared to their IVF counterparts. Out of 109 genes, 67 were
upregulated in IVF embryos compared to CT embryos and
donor cells (top 30 in Table 3). Forty two genes were
upregulated in CT embryos (top 30 in Table 4).
Functional classification of genes
The Gene Ontology (GO) information for each probe set
recovered from NetAffx Analysis Center (Bovine GeneChip November 2007 annotation) was still incomplete
for several probe sets, which lacked annotation for at least
one of the three ontologies Biological Process (BP),
Molecular Function (MF), and Cellular Component (CC).
The annotation was complemented with information
retrieved using the GOAnna tool part of the AgBase
resource at Mississippi State University. All the GO terms
associated to each gene were uploaded into the AgBase
tool GOSlimViewer in order to obtain a high level summary of the GO categories and create graphs for a better
visualization of the data, determining which classes of
gene products are over-represented or under-represented
on each of the three ontologies for cloned embryos compared to IVF embryos. GOSlimViewer results are summarized in Figures 3, 4 and 5.
Gene expression analysis by real time RT-PCR
In order to confirm the accuracy of microarray data, the
following 11 genes were selected based on their relevance
during embryonic development: DNMT3A, DNMT3B,
IGF2R, PLAC8, PGR, BIT1, HMGN3, HSPA1A, NGDN,
FBXO9, and GNAI2 (Table 5). The expression patterns of
the selected genes, obtained by Real time PCR, were consistent with the results from the DNA microarray analysis
(Figure 6 and 7 ). The analysis of gene expression in the
cell lines showed that both housekeeping genes, GAPDH
and 18S ribosomal RNA, had a similar pattern of expression. The internal standard 18S ribosomal RNA values
were 1.5 times greater in all groups than those of GAPDH.
After normalization based on both housekeeping genes,
there were no differences among the groups for NFYA and
Taspase 1 genes. Both G1 and G2 cell lines had significantly greater concentration of PALLD transcript compared to G0, G4 and, and G5. For GATM, the transcript
levels of G5 were significantly lower than in all of the
other groups (Figure 8).
Data modelling
The pathways originated using Ingenuity Pathway Analysis showed the most important pathways in which the differentially expressed genes participate. The top networks
formed by the genes upregulated in IVF embryos compared to both CT groups included cellular growth and
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Figure 2 clustering of microarray hybridizations
Hierarchical
Hierarchical clustering of microarray hybridizations. Cluster analysis of hybridizations and genes performed using GeneTraffic UNO (Iobion Informatics LLC). All donor cells were clustered in one group, while all the embryos were clustered in a
second group. The embryos clearly separate into two groups: a group containing the IVF embryos and a group containing the
chromatin transfer embryos.
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Table 1: Number of differentially expressed transcripts in pairwise comparisons between IVF embryos, CT1 embryos, CT4 embryos,
DC1 cells, and DC4 cells (p-value < 0.01 and fold change > 2.0)

1
2
3
4
5
6
7
8
9
10

Comparison
Group 1 vs. Group 2

Differentially expressed transcripts

Higher in the first group

Higher in the second group

IVF embryos vs. CT-1 embryos
IVF embryos vs. CT-4 embryos
IVF embryos vs. DC-1 cells
IVF embryos vs. DC-4 cells
CT-1 embryos vs. CT-4 embryos
CT-1 embryos vs. DC-1 cells
CT-1 embryos vs. DC-4 cells
CT-4 embryos vs. DC-1 cells
CT-4 embryos vs. DC-4 cells
DC-1 cells vs. DC-4 cells

270a
411a
3360c
3428c
193a
2459b
2588b
2036b
2276b
83d

123
193
1548
1593
91
1238
1379
1151
1287
34

147
218
1812
1835
101
1221
1209
885
989
49

Different subscripts indicate statistically significant differences in the number of differentially expressed transcripts.

proliferation, embryonic development, cellular assembly
and organization, cellular death and response to stress
(Figure 9). On the other hand the networks obtained from
the transcripts more abundant in the cloned blastocysts
compared to IVF embryos were cellular morphology cellular development, cell signaling, and metabolism (Figure
10). Genes with a putative cumulative misregulation after
serial rounds of chromatin transfer are presented on
Tables 6 and 7.

large offspring syndrome [38-40]. In the case of embryos
produced by SCNT, besides the alterations due to in vitro
culture conditions, gene expression defects may be caused
by improper silencing and activation of specific genes,
altered chromatin remodelling, and epigenetic alterations
[41]. But identifying key genes responsible for the general
developmental failure in cloned embryos is not an easy
task, since the alterations may be caused by a variety of
factors including donor cell type, cell cycle stage, nuclear
transfer protocol, source of the oocytes, embryo culture
system, embryo transfer procedure, recipient cows management, and operators' skills [42]. Consequently, there is

Discussion
It has been reported that in vitro culture conditions alter

Table 2: Classification of differentially expressed probe sets in pairwise comparisons

Comparisons
Probe set category

IVF vs.
CT1

IVF vs.
CT4

IVF vs.
DC1

IVF vs.
DC4

CT1 vs.
CT4

CT1 vs.
DC1

CT1 vs.
DC4

CT4 vs.
DC1

CT4 vs.
DC4

DC1 vs.
DC4

Genes
Similar to...
Hypothetical proteins
cDNA clones
Transcripts with strong
similarity to a known
gene
Transcripts with
moderate similarity to a
known gene
Transcripts with weak
similarity to a known
gene
Unknown transcripts

63
106
4
0
1

104
180
10
1
3

747
1564
90
24
26

763
1597
102
28
23

44
81
0
0
0

574
1071
69
19
17

563
1132
80
16
17

421
898
65
17
19

461
995
76
16
21

23
34
6
0
0

2

0

24

27

2

13

16

12

14

2

1

0

13

15

1

10

17

8

10

0

93

113

872

873

64

686

747

596

683

18

Total

270

411

3360

3428

192

2459

2588

2036

2276

83

The probe set categories correspond to NetAffx Bovine GeneChip (Nov. 2007 Annotation).

gene expression and may lead to developmental aberrations in IVF derived cattle, commonly referred to as the

a big variety of alterations that are not always shared by all
cloned embryos. Still, the common thread uniting many

Page 6 of 23
(page number not for citation purposes)

BMC Genomics 2009, 10:190

http://www.biomedcentral.com/1471-2164/10/190

Table 3: Top 30 upregulated genes, in IVF blastocysts compared to CT blastocysts sorted by P-value

Probe set ID

Gene Title

Bt.28010.1.S1_at
Bt.21013.1.S1_at
Bt.28223.1.S1_at
Bt.9525.1.A1_at
Bt.2892.1.S1_at
Bt.4430.1.S2_at

Peptidase inhibitor 3, skin-derived (SKALP)
Polo-like kinase 3 (Drosophila)
20-beta-hydroxysteroid dehydrogenase-like
Zinc finger protein 183
Fatty acid binding protein 7, brain
ATPase, H+ transporting, lysosomal V0
subunit a1
Bt.5154.1.S1_at
Heat shock 70 kDa protein 1A
Bt.15787.1.S1_at
Bcl-2 inhibitor of transcription
Bt.13544.2.S1_a_at Zinc finger protein 410
Bt.2005.1.S1_at
LSM1 homolog, U6 small nuclear RNA
associated
Bt.16291.1.A1_at
Testis expressed 12
Bt.27854.1.S1_at
Nuclear factor, interleukin 3 regulated
Bt.13928.2.S1_a_at Sodium channel modifier 1
Bt.15334.2.A1_at
Signal transducer and activator of
transcription 3
Bt.12506.1.S1_at
Serpin peptidase inhibitor, E member 2
Bt.20204.1.S1_at
Sjogren's syndrome/scleroderma autoantigen
Bt.20199.1.A1_at
DEAD (Asp-Glu-Ala-Asp) polypeptide 56
Bt.3359.1.S1_at
General transcription factor IIF, polypeptide
Bt.2958.1.A1_at
Ubiquitin-conjugating enzyme E2A
(RAD6 homolog)
Bt.3002.1.S1_at
BUB3 budding uninhibited by benzimidazoles
3
Bt.6087.1.S1_at
Transmembrane 4 superfamily member 1
Bt.4737.1.S2_s_at
Prion protein
Bt.1854.1.S1_at
Intraflagellar transport 20 homolog
(Chlamydomonas)
Bt.5340.1.S1_s_at
Nucleoside-diphosphate kinase NBR-A
Bt.8.1.S1_at
Keratin 10 (epidermolytic hyperkeratosis)
Bt.27095.1.S1_at
Collaborates/cooperates with ARF protein
Bt.5039.1.S1_at
High mobility group nucleosomal binding
domain 3
Bt.27874.1.S1_s_at Phosphatidylserine receptor
Bt.4595.1.S1_at
TSR2, 20S rRNA accumulation, homolog
Bt.1505.1.S1_at
Sin3A-associated protein, 18 kDa

Gene ID

P value

Fold change IVF/CT1 Fold change IVF/CT4

PI3
PLK3
MGC127133
ZNF183
FABP7
ATP6V0A1

0.000000
0.000001
0.000009
0.000057
0.00014
0.00014

5.58
3.99
2.13
2.13
1.22
1.89

9.12
9.09
1.71
3.62
6.35
1.93

HSPA1A
BIT1
ZNF410
LSM1

0.0002
0.0002
0.0003
0.0003

4.14
1.49
2.01
1.86

7.17
2.01
1.90
1.57

TEX12
NFIL3
SCNM1
STAT3

0.0004
0.0004
0.0004
0.0005

3.40
1.72
2.02
4.71

3.64
3.08
4.05
16.06

SERPINE2
SSSCA1
DDX56
GTF2F1
UBE2A

0.0005
0.0005
0.0006
0.0009
0.001

1.52
1.61
1.45
1.53
2.03

1.42
2.93
1.79
1.98
3.08

BUB3

0.001

1.27

1.62

TM4SF1
PRNP
IFT20

0.001
0.001
0.001

2.29
2.20
1.65

6.62
2.99
2.30

NBR-A
KRT10
CARF
HMGN3

0.002
0.002
0.002
0.002

1.42
1.98
1.53
1.72

1.76
3.39
2.97
2.96

PTDSR
TSR2
SAP18

0.002
0.002
0.003

2.29
2.08
2.24

2.99
2.59
2.48

Genes were analyzed by one-way ANOVA.

of the SCNT failures can be traced to epigenetic alterations, specifically failures in chromatin remodelling and
DNA and histone methylation [13,43,44]. The fetal
fibroblast cells used in this study are not fully representative of adult somatic cells. However, these cells were chosen because of their practicality and higher efficiency in
SCNT studies.
Microarray analysis has been used to explore the transcriptome profile of cloned embryos relative to that of the
donor cells and IVF embryos as a control. However, the
appropriate microarray platform is crucial in order to
detect changes in particular genes. Smith and colleagues
reported similar transcriptome profiles for cloned blastocysts and blastocysts produced by artificial insemination
[15]. However, the cDNA microarray used by Smith and
colleagues consisted of placenta and spleen cDNA librar-

ies, lacking embryonic genes, which therefore were not
analysed. The results from the present study show an
extensive reprogramming in cloned embryos by the blastocyst stage. However, the data point to a group of differentially expressed transcripts between IVF and cloned
blastocysts.
Serial cloning is often performed for the production of
transgenic animals. Although apparently healthy animals
can be obtained after serial cloning, the efficiency of cloning decreases from generation to generation despite comparable blastocyst and early pregnancy rates. This increase
in pregnancy losses and perinatal deaths could be caused
by gene expression defects accumulated throughout the
serial cloning procedures, which could be detected in
blastocysts, although no phenotypic alterations are
observed at this stage. Furthermore, it has been proposed
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Table 4: Top 30 genes upregulated in CT blastocysts and donor cells compared to IVF blastocysts, sorted by P-value

Probe set ID

Gene Title

Bt.8933.1.S1_at
Adaptor-related protein complex 3, sigma 2
Bt.27382.1.A1_s_at X-ray repair complementing defective repair in
Chinese hamster cells 1
Bt.22224.1.S1_at
insulin receptor substrate 4
Bt.3220.1.S1_at
Crystallin, lambda 1
Bt.7805.2.S1_a_at
Nuclear casein kinase and cyclin-dependent
kinase substrate 1
Bt.29540.1.S1_at
Arginine/serine-rich coiled-coil 1
Bt.19690.1.A1_at
Paraoxonase 1
Bt.20444.1.S1_at
thyroid hormone receptor associated protein 5
Bt.16122.1.S1_at
Sorbitol dehydrogenase
Bt.5737.1.S1_at
vacuolar protein sorting 26 homolog A
Bt.4292.1.S1_at
ARP3 actin-related protein 3 homolog (yeast)
Bt.18230.1.S1_a_at Nuclear autoantigenic sperm protein
Bt.9107.1.S1_a_at
phosphatidylinositol binding clathrin assembly
protein
Bt.663.1.S1_at
Palladin, cytoskeletal associated protein
Bt.1743.2.S1_a_at
Phenylalanyl-tRNA synthetase 2, mitochondrial
Bt.13205.1.A1_at
Mitochondrial ribosomal protein S35
Bt.25100.1.A1_at
Cortactin
Bt.783.1.S1_at
Aldehyde oxidase 1
Bt.23608.1.S1_s_at Keratin 8
Bt.27284.1.S1_at
Eukaryotic translation initiation factor 4H
isoform 2
Bt.10898.1.S1_at
Tumor differentially expressed 2-like
Bt.28745.1.S1_at
Coagulation factor II receptor-like 1
Bt.5267.1.S1_at
Annexin A6
Bt.355.1.S1_at
Caldesmon 1
Bt.20084.2.S1_at
Casein kinase 1, epsilon
Bt.2823.3.S1_a_at
Chromosome 1 open reading frame 35
Bt.7671.1.S1_at
Interferon induced transmembrane protein 1
Bt.5319.1.S1_at
Anti-oxidant protein 2
(independent phospholipase A2)
Bt.23263.1.S1_s_at Heat shock 90 kDa protein 1, beta
Bt.19709.1.S1_at
LAG1 homolog, ceramide synthase 2

that the extended culture, associated with transfection and
selection procedures, may induce changes in the donor
cells [36]. The present studies show that serial cloning
does not significantly affect transcriptional reprogramming of cloned blastocysts. The global transcriptome profile of blastocysts from four consecutive rounds of cloning
did not significantly differ from the one obtained from
blastocysts after only one round of cloning. However, for
a set of genes, misregulation was significantly greater in
the blastocysts obtained from four rounds of cloning (see
Tables 6 and 7). However the observed differences
between blastocysts from the first and fourth rounds of
cloning could be due to the fact that these are different
donor cells and not of the same clonal origin.
To our knowledge this is the first study to focus on the
influence of serial chromatin transfer on global transcriptome profile of embryos and donor cells. Only a small
proportion of the data set generated by the present study
corresponded to fully annotated bovine genes (Table 2).

Gene ID

P value Fold change CT1/IVF Fold change CT4/IVF

AP3S2
XRCC1

0.0001
0.0001

1.61
2.60

2.21
2.54

IRS4
CRYL1
NUCKS1

0.0002
0.0003
0.0003

2.31
1.94
3.14

2.10
1.82
3.47

RSRC1
PON1
THRAP
SORD
VPS26
ACTR3
NASP
PIBCAP

0.0004
0.0005
0.0006
0.0008
0.0008
0.0008
0.0011
0.0014

1.57
1.53
1.60
2.59
2.33
1.69
1.95
1.83

3.09
3.74
1.20
3.40
3.38
1.69
2.75
2.93

PALLD
FARS2
MRPS35
CTTN
AOX1
KRT8
WBSCR1

0.0019
0.0021
0.0023
0.0026
0.0029
0.0030
0.0038

2.88
1.64
1.44
1.26
1.99
3.99
2.21

3.08
2.98
2.29
1.58
3.67
4.59
1.55

TDE2L
F2RL1
ANXA6
CALD1
CSNK1E
C1orf35
IFITM1
AOP2

0.0041
0.0045
0.0046
0.0047
0.0053
0.0058
0.0069
0.0071

1.98
2.25
1.92
1.71
3.90
1.45
2.47
2.03

5.08
1.85
3.79
1.79
2.64
1.78
2.60
3.70

HSP90AB1
LASS2

0.0072
0.0072

1.30
1.25

1.90
1.69

The rest of the probe sets were excluded from further analyses due to lack of annotations. Progress in the annotation
of the bovine genome will greatly facilitate global gene
expression studies in the bovine species.
In the present study, multiple comparisons revealed five
distinctive patterns of differential gene expression among
all embryos and donor cells. The first pattern corresponded to 1,183 transcripts (30.74% of the data set) that
had similar abundance in all five groups. Housekeeping
genes like GAPD and Actin showed this pattern of expression. The second pattern corresponded to genes that had
similar expression in IVF and CT embryos, but had a very
different pattern of expression in both donor cell lines.
We hypothesised that these are genes that switched from
the "donor cell gene expression mode" to the "embryo
gene expression mode". The majority of the genes in the
data set (76.49%) showed this pattern, including some
imprinted and embryonic specific genes such as the Oct-4
protein coding gene (POU5F1), which has been reported

Page 8 of 23
(page number not for citation purposes)

BMC Genomics 2009, 10:190

http://www.biomedcentral.com/1471-2164/10/190

5%

nucleus

31%
35%

membranes and envelops

27%
25%

intracellular

20%
5%
6%

extracelular component

5%

mitochondrion

0%
25%

unknown

15%
0%

5%

10%

15%

20%

25%

30%

35%

40%

GoSlimViewer
Figure 3
graph of Cellular Component over-represented terms in IVF and CT embryos
GoSlimViewer graph of Cellular Component over-represented terms in IVF and CT embryos. Sub-cellular locations of gene products found at high levels in both IVF blastocysts (solid bars) and both groups of CT blastocysts (open bars).
The proportion of genes present in the nucleus was higher in IVF embryos (31%) compared to CT embryos (5%). There were
more membrane and intracellular genes in CT embryos compared to IVF embryos.

15%

signaling pathways

24%
5%

transcription
development

23%
0%
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cell death
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GoSlimViewer
Figure 4
graph of Biological Process over-represented terms in IVF and CT embryos
GoSlimViewer graph of Biological Process over-represented terms in IVF and CT embryos. Biological processes
of gene products found at high levels in both IVF blastocysts (solid bars) and CT blastocysts (open bars). No genes involved in
development were upregulated in CT blastocysts compared to IVF blastocysts, for which 11% of the genes were involved in
development. Conversely a greater proportion of metabolism genes were overrepresented in CT embryos compared to IVF
embryos.
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Figure 5
GoSlimViewer
graph of Molecular Function over-represented terms in IVF and CT embryos
GoSlimViewer graph of Molecular Function over-represented terms in IVF and CT embryos. Molecular functions
of gene products found at high levels in IVF blastocysts (solid bars) and CT blastocysts (open bars). Genes with receptor function were higher in IVF blastocysts, while genes with catalytic, signal transduction and transporter functions were overrepresented in CT blastocysts.

as differentially expressed for cloned embryos in previous
studies [21,23]. Placenta specific 8 (PLAC8) also shows
this pattern of expression (Figure 6A). It is possible that
some genes, due to their methylation pattern in the
somatic cells or to their location in the chromosome, are
more likely to be reprogrammed by the oocyte factors.

(HMGN3) a gene involved in chromatin remodelling, a
vital process during embryonic genome activation (Figure
6C). The importance of both genes during morulae and
blastocyst formation could make them good candidates in
understanding the lower developmental rates of cloned
embryos.

The third pattern corresponded to genes with a similar
pattern of expression for CT embryos and donor cells, and
a very different expression pattern in IVF embryos. These
were 147 (3.81%) genes with apparently incomplete
reprogramming, probably with a somatic cell pattern of
expression. The heat shock 70 kD protein 1 (HSPA1A),
involved in cell protection from stress and apoptosis was
significantly higher in IVF embryos when compared to CT
embryos and donor cells (Figure 6B). Important embryonic genes showed this pattern of expression. Desmocollin 3 (DSC3) a transmembrane glycoprotein, involved in
cell adhesion that belongs to the cadherin family, was
present in IVF embryos but was absent in CT embryos and
donor cells. The signal transducer and activator of transcription 3 (STAT3), was significantly upregulated in IVF
embryos when compared to both groups of cloned
embryos and donor cells. A similar pattern was observed
for high mobility group nucleosomal binding domain 3

The fourth group of genes corresponded to only 85 probe
sets (2.21%) with a marked differential expression in all
cloned embryos compared to the one observed in both
IVF embryos and donor cells. The misregulation of these
genes could point to a compensation mechanism after
chromatin transfer. Genes with this kind of expression
pattern included prostaglandin-endoperoxide synthase
(PTGS2) and the transcription factor GATA-2. Both genes
had a greater microarray signal in all CT embryos, but low
expression in IVF and donor cells. The imprinted gene glycine amidinotransferase (GATM), showed significantly
greater values in the cloned embryos compared to IVF
embryos and donor cells. Two interesting genes in this
group were DNMT3A and DNMT3B transcripts, which are
responsible for de novo methylation. Both genes were significantly greater in CT-1 and CT-4 embryos compared to
IVF blastocysts (Figure 6D and 6E), which is consistent
with the hypermethylation often reported in cloned blas-
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Table 5: Primers used for Real time PCR validation

Genes
GAPDH_F
GAPDH_R
DNMT3A_F
DNMT3A_R
DNMT3B_F
DNMT3B_R
IGF2R_F
IGF2R_R
PLAC8_F
PLAC8_R
PGR_F
PGR_R
BIT1_F
BIT1_R
HMGN3_F
HMGN3_R
HSPA1A_F
HSPA1A_R
NGDN_F
NGDN_R
FBXO9_F
FBXO9_R
GNAI2_F
GNAI2_R
PALLD_F
PALLD_R
NFYA_F
NFYA_R
GATM_F
GATM_R
TASPASE1_F
TASPASE1-R

Primer sequences and positions (5' - 3')

Fragment size (bp)

TGCTGGTGCTGAGTATGTGGT
(333–354)
AGTCTTCTGGGTGGCAGTGAT
(627–648)
CTGGCTCTTTGAGAATGTGGTG
(2372–2394)
TCACTTTGCTGAACTTGGCTATT
(2607–2630)
GGGAAGGAGTTTGGAATAGGAG
(698–720)
CTCTGGTTGCTTGTTGTTAGGTT
(1114–1137)
AACCAGGTGATTTAGAAAGTGCC (1939–1962)
CGCTTCTCGTTATTGTAGGGTG
(2335–2357)
TGTTTCACAGCCAGGTTACAGC
(168–190)
GGGTCCGATACATTGTCCTCAT
(367–389)
TAAATGACCAGCAAGCAGAAACT
(562–585)
GGTAATTGTGCAGCAATAACCTC
(955–978)
CGGAGCCAGAGGAAGAATGA
(75–95)
TGCTTGTAGGCAGAAACAGCA
(519–530)
GTTCCAGCCCGTTGCTTTAC
(22–42)
GACCATTCATTCTCCCTCGTTAG
(376–399)
CACGATGTTGATCCTGTGGG
(86–106)
CACCTTAGGCTTGTCTCCGTC
(465–487)
GTGAGAATGACCCACTCCGTT
(403–424)
TCCCGCTTGCTGACACTTAA
(799–819)
GCAGACGGCAGGAGTAGACAC
(231–252)
ACAAGTTGCATAGCCCTACGAT
(675–697)
TCCAGACAACTGCCAACATCA
(1978–1999)
CAAACCAGGTGAACAATTCCATA
(2192–2215)
AGGTTGACCTACGAGGAAAGGA
(2071–2092)
ATGTGAACGTCGCAGGCATA
(2362–2382)
CGGGCTAAATTAGAAGCAGAAG
(998–1020)
AGGGCAGAATGTGATCGTCAG
(1308–1329)
ATTGGCTGCTCAGGGAAAGT
(824–844)
ACATGGTCGGTCAGGGTTG
(1085–1104)
CAAGACTCATATTTCCAGACTCCC
(1145–1169)
CCAAGCACTAACTACAGCAGCAC
(1408–1431)

tocysts. These results do not agree with previous findings,
in which DNMT3A was downregulated in NT embryos
compared to IVF embryos [21]. Zhou et al., reported similar levels of DNMT3B for embryos produced in vivo, in
vitro, and by different nuclear transfer methods, including
chromatin transfer [9]. These contrasting results confirm
that alterations greatly vary and are not shared by all
cloned embryos. One limitation of our study is that we
have not used in vivo blastocysts which might have provided more biological means and as the physiological
standard against in vitro culture conditions.
A fifth pattern corresponded to genes that had an increasing or a decreasing pattern of expression from IVF
embryos through donor cells showing an intermediate
pattern of expression in CT embryos. In total, 245 probe
sets showed this pattern of expression with 119 (3.08%)
increasing, and 126 (3.28%) decreasing from IVF through
DC. It could be assumed that these genes have been partially reprogrammed, since their transcript abundance is
in between IVF and donor cells. The imprinted gene insu-

Accession Number

295

[GenBank:XM_865742]

236

[GenBank:XM_867643]

417

[GenBank:NM_181813]

397

[GenBank:NM_174352]

200

[GenBank:NM_001025325]

394

[GenBank:XM_613908]

445

[GenBank:NM_001034519.1]

355

[GenBank:NM_001034504.1]

380

[GenBank:NM_174550.1]

397

[GenBank:NM_001046459]

445

[GenBank:NM_001034412.1]

215

[GenBank:XM_589440.3]

292

[GenBank:XM_869983.2]

311

[GenBank: NM_001014956.1]

262

[GenBank: NM_001045878.1]

264

[GenBank: NM_001034577.1]

lin-like growth factor 2 receptor (IGF2R), one of the most
studied genes in the large offspring syndrome, showed
similar expression values in IVF and CT1 embryos, but significantly higher signals in CT4 embryos, and very high
signals in both donor cells (Figure 6F). These higher
mRNA levels in the fourth generation of cloning could
indicate a cumulative misregulation of this gene. The Bcl2 inhibitor of transcription (BIT1) showed the greatest
values in IVF embryos, intermediate values in CT embryos
and the lowest values in donor cells (Figure 7A). The
nuclear transcription factor Y, alpha (NFYA), showed a
similar expression pattern in both IVF and CT1 embryos;
although it was significantly lower in CT4 embryos and
donor cells. Neuroguidin (NGDN), an eukaryotic translation initiation factor with important functions in embryonic development was another gene with a decreasing
pattern of expression (Figure 6B). Genes with and increasing pattern of expression included F-box protein 9
(FBXO9), and guanine nucleotide binding protein alpha
inhibiting activity polypeptide 2 (GNAI2) represented in
Figure 6C and Figure 6D, respectively. Transcripts for the
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Table 6: Genes with putative cummulative downregulation in blastocysts obtained after serial rounds of chromatin tranfer

Probe Set ID

Bt.5154.1.S1_at

Gene Title

heat shock 70 kD protein
1
Bt.9759.1.S1_a_at neuroguidin, EIF4E binding
protein
Bt.5039.1.S1_at
high mobility group
nucleosomal binding
domain 3
Bt.9759.2.S1_at
neuroguidin, EIF4E binding
protein
Bt.4737.1.S2_s_at
prion protein
Bt.1854.1.S1_at
intraflagellar transport
protein 20
Bt.27874.1.S1_s_at phosphatidylserine
receptor
Bt.15787.1.S1_at
Bcl-2 inhibitor of
transcription
Bt.20204.1.S1_at
Sjogren's syndrome/
scleroderma autoantigen 1
Bt.4595.1.S1_at
TSR2, 20S rRNA
accumulation, homolog
(S. cerevisiae)
Bt.12250.1.S1_at
chromosome 14 open
reading frame 10
Bt.27095.1.S1_at
collaborates/cooperates
with ARF (alternate
reading frame) protein
Bt.13928.2.S1_a_at sodium channel modifier 1
Bt.6620.1.S1_at
myosin, heavy polypeptide
7, cardiac muscle, beta
Bt.19972.1.S1_at
proton-dependent
gastrointestinal peptide
transporter
Bt.28010.1.S1_at
protease inhibitor 3, skinderived (SKALP)
Bt.5126.1.S1_at
hypertension-related
calcium-regulated gene
Bt.22523.1.S1_at
dispatched homolog 1
(Drosophila)
Bt.5828.1.S1_at
SERTA domain containing
1
Bt.333.1.S1_at
transition protein 1 (during
histone to protamine
replacement)
Bt.14098.1.S1_at
microtubule-associated
protein, RP/EB family,
member 2
Bt.4158.1.A1_at
oviduct specific
glycoprotein
Bt.22856.1.S1_at
neurofilament, medium
polypeptide
Bt.9807.1.S1_at
glycoprotein
(transmembrane) nmb
Bt.23151.1.S1_at
fucosyltransferase 10
(alpha (1,3)
fucosyltransferase)
Bt.7239.1.S1_at
solute carrier family 6
(neurotransmitter
transporter, dopamine),
member 3
Bt.12739.2.S1_a_at membrane-associated ring
finger (C3HC4) 2
Bt.6556.1.S1_at
regakine-1 protein

Gene Symbol

IVF

CT1

CT4

Fold change IVF/
CT1

Fold change IVF/
CT4

HSPA1A

16655.53 4021.00 2975.26

4.14

5.60

NGDN

11691.84 5346.60 3041.70

2.19

3.84

HMGN3

11195.32 6522.85 4078.53

1.72

2.74

NGDN

5999.87 2431.02 1665.35

2.47

3.60

PRNP
IFT20

3552.73 1614.40 1425.30
3526.47 2139.25 1380.10

2.20
1.65

2.49
2.56

PTDSR

3476.73 1517.25

980.58

2.29

3.55

BIT1

2989.58 2007.15 1415.27

1.49

2.11

SSSCA1

1695.08 1056.05

579.62

1.61

2.92

TSR2

1567.39

755.35

568.11

2.08

2.76

C14orf10

1525.13

981.80

567.59

1.55

2.69

CARF

1390.25

907.40

668.85

1.53

2.08

SCNM1
MYH7

786.05
673.53

390.50
219.15

249.35
135.85

2.01
3.07

3.15
4.96

PEPT1

567.85

189.46

170.27

3.00

3.34

PI3

510.98

91.50

56.05

5.58

9.12

COMMD5

449.40

335.50

176.24

1.34

2.55

DISP1

402.17

174.75

155.13

2.30

2.59

SERTAD1

357.71

287.95

157.44

1.24

2.27

TNP1

233.38

155.00

98.93

1.51

2.36

MAPRE2

199.89

183.45

69.82

1.09

2.86

OVGP1

196.48

168.70

78.09

1.16

2.52

NEF3

188.69

126.35

46.89

1.49

4.02

GPNMB

154.95

52.30

24.03

2.96

6.45

FUT10

154.43

114.10

55.12

1.35

2.80

SLC6A3

149.32

48.30

21.24

3.09

7.03

C3HC4

110.18

51.40

23.87

2.14

4.62

89.66

25.75

39.07

3.48

2.29

LOC504773
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Table 6: Genes with putative cummulative downregulation in blastocysts obtained after serial rounds of chromatin tranfer (Continued)

Bt.12080.2.S1_at
Bt.13036.1.S1_at
Bt.2157.1.S1_a_at
Bt.28409.2.S1_at
Bt.3771.1.A1_at
Bt.27752.1.S1_at
Bt.13024.2.S1_at
Bt.28017.1.S1_at
Bt.512.1.S1_at

Bt.12928.1.S1_at
Bt.29129.1.S1_at

Bernardinelli-Seip
congenital lipodystrophy 2
progesterone receptor
RPGR-interacting protein
1
DNA replication factor
Nucleolar protein family A,
member 1
tensin 4
purinergic receptor P2Y
G-protein coupled, 2
vacuolar H+-ATPase
nucleotide
phosphodiesterase, 3'-5'cyclic
Interleukin 13
anterior gradient 2
homologue

BSCL2

88.59

38.70

13.83

2.29

6.41

PGR
RPGRIP1

79.73
77.03

4.69
58.90

36.57
6.56

17.02
1.31

2.18
11.75

CDT1
NOLA1

71.69
69.73

55.20
21.50

12.73
21.26

1.30
3.24

5.63
3.28

TNS4
P2RY2

69.66
67.08

43.05
46.15

8.73
22.11

1.62
1.45

7.98
3.03

LOC407191
PDE1A

65.07
60.70

34.20
15.59

17.47
15.85

1.90
3.89

3.73
3.83

IL13
agr2

58.85
45.07

37.70
39.00

9.25
21.29

1.56
1.16

6.36
2.12

(P < 0.01).

progesterone receptor (PGR) were significantly higher in
IVF embryos compared to CT embryos and donor cells
(Figure 6E). Among this group of transcripts could be
genes that are cumulatively affected be serial cloning.
Based on the difference in gene expression for RARB,
CRAB1, THBS, SERPINB5, and HLA-A, Beyhan et al. suggest a possible role for the retinoic acid signalling pathway
in the failures observed in cloned bovine embryos [22].
However the bovine GeneChip does not contain a Retinoic Acid Receptor Beta (RARB) probe set. It only contains
a probe set that corresponds to a bovine EST with similarity to the rat RARB (Bt.21044.2.A1_at). In the present
data, CRAB1 and THBS2 were slightly higher in IVF
embryos, although without statistical significance. They
also found differential gene expression among several
genes in both donor cells (CDKN1C, COPG2, DCN,
GATM, MEST, NDN, NNAT, PON3, and SGCE). In the
current study GATM was significantly downregulated in
donor cells from the fifth successive generation of chromatin transfer (Figure 7).
At the blastocyst stage there is an extensive reprogramming of cloned embryos leading to very similar transcriptomes in IVF and CT blastocysts. However, there were
around 200 differentially expressed genes in both CT
embryos compared to IVF. For some genes, the differences
were significantly greater in CT4 when compared to CT1,
suggesting a possible cumulative missregulation caused
by serial cloning. Genes involved in transcription, cellular
proliferation, embryonic development, cellular death,
and response to stress are over represented in IVF
embryos; many of these genes are present in the nucleus,
which was the cell component overrepresented in IVF
embryos. Genes involved in cell morphology, cell development, and metabolism were over expressed in donor

cells and in cloned embryos when compared to IVF, suggesting that they were not properly silenced in the donor
nucleus. The up regulation of genes involved in metabolism should be further explored as it could be linked to the
large size of cloned animals.

Conclusion
As gene expression profile can only show one step in cell
phenotype and function control, namely transcriptome
regulation, proteomic analysis could complement this
study by providing a more complete picture of the regulation of embryonic development. With a more complete
bovine genome annotation, more of the differentially
expressed transcripts could be analyzed further providing
more information for the currently unidentified transcripts, which, in the present study represented around
18% of the dataset. Gene Ontology information for a proportion of the differentially expressed genes is still incomplete. Thus, for some of the genes the cellular component
is known, but the biological process and/or its molecular
function is not documented. It is interesting that the
majority of genes upregulated in CT blastocysts participate in metabolism processes, while the percentage of
metabolism genes in IVF blastocyst was lower compared
to signalling pathway genes.
The present study provides a data set that could be useful
in identifying epigenetic errors in cloning and may facilitate our understanding of the reprogramming process in
SCCT. Future studies should involve more of the successive generations of cloned embryos and their respective
donor cells to identify cumulative misregulated genes.
Gene expression studies from fetal, newborn, and placental tissues could identify genes that are responsible for
abnormalities, abortions, stillborns and low birth rate.
Functional studies should target particular genes that play
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Table 7: Genes with putative cummulative upegulation in blastocysts obtained after serial rounds of chromatin tranfer

Probe Set ID

Bt.4475.1.S1_at

Gene Title

NADH dehydrogenase
(ubiquinone) Fe-S protein
2, 49 kDa
(NADH-coenzyme Q
reductase)
Bt.3583.1.S1_at
villin 2
Bt.663.1.S1_at
palladin, cytoskeletal
associated protein
Bt.9068.1.S1_at
non-muscle myosin heavy
chain
Bt.2841.1.S1_at
tryptophanyl-tRNA
synthetase
Bt.4311.1.S1_at
guanidine nucleotide
binding protein, (G
protein), alpha inhibiting
activity polypeptide 2
Bt.962.1.S1_at
golgi autoantigen, golgin
subfamily a, 7
Bt.760.1.S1_at
zinc finger protein 313
Bt.803.1.A1_at
chromatin modifying
protein 1B
Bt.4503.1.S1_at
mitochondrial carrier
homolog 2
Bt.23603.3.S1_at
F-box protein 9
Bt.7169.1.S1_at
methylmalonyl Coenzyme
A mutase
Bt.14010.1.S1_at
leukotriene B4 12hydroxydehydrogenase
Bt.8933.1.S1_at
adaptor-related protein
complex 3, sigma 2
subunit
Bt.12261.1.A1_at
taspase 1
Bt.4738.1.S1_at
calpastatin
Bt.26764.1.A1_at
Lectomedin 2
Bt.1388.1.S1_at
Abl-philin 2 isoform 2
Bt.20236.1.S1_at
thrombospondin repeat
containing 1
Bt.5330.1.S1_at
lysosomal-associated
membrane protein 1
Bt.8870.3.S1_at
CGI-119 protein
Bt.23209.1.S1_a_at lectomedin 2
Bt.318.1.S1_at
adrenergic, beta 3,
receptor
Bt.4057.1.S1_at
myosin, heavy polypeptide
10, non-muscle
Bt.4560.1.S1_s_at
trophoblast Kunitz
domain protein 1
Bt.22858.1.S1_at
uroplakin IIIB
Bt.12304.1.S1_at
interferon-stimulated
protein, 15 kDa
Bt.26830.2.S1_a_at 5,10methylenetetrahydrofolat
e reductase (NADPH)
Bt.5101.1.S1_at
prion protein interacting
protein
Bt.17862.1.A1_at
Guanine nucleotide
binding protein (G
protein), alpha stimulating
activity polypeptide 1
Bt.2301.1.S1_at
Zinc finger protein 325
(gonadotropin inducible
transcription repressor-3)

Gene Symbol

IVF

CT1

CT4

Fold change IVF/
CT1

Fold change IVF/
CT4

NDUFS2

6724.02 13373.15 14960.42

1.99

2.22

VIL2
PALLD

6698.24 13698.40 17209.52
5038.25 14502.45 19368.34

2.05
2.88

2.57
3.84

LOC404108

3,972.71

6,504.05

8,152.57

1.64

2.05

WARS

2,665.06

4,276.85

5,569.16

1.60

2.09

GNAI2

2,389.08

3,859.15

7,740.86

1.62

3.24

GOLGA7

1,689.70

2,728.90

4,288.07

1.62

2.54

Znf313
CHMP1B

1,523.55
1,315.99

2,140.45
2,093.75

3,126.63
3,934.13

1.40
1.59

2.05
2.99

Mtch2

1,279.84

3,359.75

4,555.63

2.63

3.56

FBXO9
MUT

1,058.76
898.23

1,948.25
1,622.10

2,813.78
1,943.02

1.84
1.81

2.66
2.16

LTB4DH

841.63

5688.55 11345.50

6.76

13.48

AP3S2

667.54

1,071.50

1,425.67

1.61

2.14

C20orf13
CAST
LEC2
ZDHHC16
ADAMTSL4

435.56
329.41
307.46
286.19
211.65

1,113.20
504.45
1,085.70
630.40
322.35

1,293.73
890.74
1,567.79
948.26
522.48

2.56
1.53
3.53
2.20
1.52

2.97
2.70
5.10
3.31
2.47

LAMP1

194.91

174.90

1,195.48

0.90

6.13

CGI-119
LEC2
ADRB3

128.16
83.06
26.17

218.35
279.90
52.65

403.76
418.46
89.07

1.70
3.37
2.01

3.15
5.04
3.40

MYH10

21.07

38.95

83.71

1.85

3.97

TKDP1

21.03

43.25

88.08

2.06

4.19

UPK3B
ISG15

16.02
15.51

16.70
67.95

100.71
66.46

1.04
4.38

6.29
4.29

MTHFR

12.02

57.85

79.11

4.81

6.58

PRNPIP

8.97

32.00

74.73

3.57

8.33

GNAS1

8.03

42.00

44.87

5.23

5.59

ZNF325

3.81

22.10

121.65

5.80

31.93
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Table 7: Genes with putative cummulative upegulation in blastocysts obtained after serial rounds of chromatin tranfer (Continued)

Bt.17862.1.A1_at

Bt.12304.1.S1_at
Bt.12261.1.A1_at
Bt.3583.1.S1_at

Guanine nucleotide
binding protein (G
protein), alpha stimulating
activity polypeptide 1
interferon-stimulated
protein, 15 kDa
taspase 1
villin 2

GNAS1

8.03

42.00

44.87

5.23

5.59

15.51

67.95

66.46

4.38

4.29

435.56 1113.20 1293.73
6698.24 13698.40 17209.52

2.56
2.05

2.97
2.57

ISG15
C20orf13
VIL2

(P < 0.01)

key roles in molecular reprogramming and early embryo
development and manipulate their mRNA concentrations
in SCCT embryos, to mimic that of IVF embryos.

Methods
In vitro fertilization (IVF)
Bovine oocytes were aspirated from 2–8 mm follicles of
abattoir-obtained ovaries from Holstein cows and
matured in Tissue Culture Medium (TCM-199, Gibco/
Invitrogen, Grand Island, NY) supplemented with 0.2
mM pyruvate, 0.5 g/ml FSH (Sioux Biochemicals, Sioux
City, IA), 5 g/ml LH (Sioux Biochemicals, Sioux City,
IA), 10% FCS (Gibco/Invitrogen, Grand Island, NY), 100
U/ml penicillin and 100 g/ml streptomycin (Gibco/Invitrogen, Grand Island, NY) in 5% CO2 in air at 38.5°C. For
fertilization, matured oocytes were transferred to fertilization medium and were fertilized using thawed sperm
from a Holstein bull separated by Percoll density gradient
and further incubated for 24 hours. Presumptive zygotes
were transferred to Gardner's culture medium 1 (G1) for
3 days, followed by 3–4 days culture in Gardner's culture
medium 2 (G2). Blastocysts were evaluated and graded
according the International Embryo Transfer Society
(IETS) guidelines [45]. Grade 1 blastocysts were selected,
pooled in groups of 3 blastocysts per tube, frozen (with
addition of lyses buffer from RNeasy MicroKit (Qiagen
Valencia, CA) in liquid nitrogen and stored in -80°C until
RNA isolation.
Chromatin transfer (CT)
In vitro-matured oocytes were enucleated at 20 hpm.
Bovine fetal fibroblasts after one and four rounds of cloning were trypsinized and washed in Ca/Mg Hank's Balanced Salt Solution (HBSS) and permeabilized by
incubation of 50,000 – 100,000 cells in 31.25 units Streptolysin O (SLO-Sigma, St. Louis, MO) in 100 l for 30
minutes in a 37°C H2O bath. Permeabilized fibroblasts
were washed, pelleted and incubated in 40 l of mitotic
extract prepared from MDBK cells containing an ATP-generating system (1 mM ATP, 10 mM creatine phosphate
and 25 g/ml creatine kinase) for 30 min at 38°C. At the
end of incubation, the reaction mix was diluted with 500
l of cell culture media (Alpha MEM with 10% FBS), pelleted and resuspended in TL Hepes. These cells were fused

to enucleated oocytes, activated 26 h after maturation
with 5 M calcium ionophore for 4 min followed by 10
g/ml of cycloheximide and 2.5 g/ml of cytochalasin D
for 5 h. After activation, embryos were washed, and cultured in SOF medium for the first 4 days with 8 mg/ml
BSA and the last three days with 10% fetal calf serum at
38.5°C and 5% CO2 in air. Grade 1 blastocysts were
pooled (3 per tube) and frozen, with addition of lysis
buffer. Embryos were stored in -80°C until RNA isolation.
Fourth generation of SCCT embryos
For subsequent rounds of cloning, CT derived bovine
blastocysts from the first generation were transferred into
hormonally synchronized cows. At seventy-days, pregnancies were interrupted, and foetuses recovered. Fetal
fibroblast cultures were established and used for the next
chromatin transfer process. The same procedure was done
3 times to provide a fourth generation of clones. Grade 1
blastocysts from the fourth generation were pooled (3 per
tube) and frozen, with addition of lysis buffer. Embryos
were stored in -80°C until RNA isolation.
Establishment of fetal fibroblast cell lines
Fetal cell lines were developed according. Seventy-day old
male bovine foetuses were recovered and transported to
the laboratory in Dulbecco's PBS (DPBS) with 16 ml/ml
of antibiotic-antimycotic (Gibco, Grand Island, NY), 4
ml/ml tylosin tartrate (Sigma, St. Louis, MO), and 8 ml/
ml fungizone (Gibco). Foetuses were rinsed in DPBS, the
head and internal organs were removed, and remaining
tissues were finely chopped into pieces with a scalpel
blade. The fibroblasts were separated from the tissue
pieces using 0.08% trypsin and 0.02% EDTA in PBS
(trypsin-EDTA). The cells were seeded onto 100-mm tissue culture plates (Corning, VWR, Chicago, IL) in a minimal essential medium (a-MEM; Gibco) supplemented
with 10% fetal calf serum (FCS; Hyclone, Logan, UT),
0.15 g/ml glutamine (Sigma), 0.003% b-mercaptoethanol
(Gibco), and antibiotic-antimycotic (Gibco). On the
same day of cloning (day 3 of seeding), the cells were harvested using DPBS with trypsin-EDTA solution and were
counted. One million cells were frozen in MEM with 10%
FCS, dimethyl sulfoxide (Sigma), and lysis buffer.

Page 15 of 23
(page number not for citation purposes)

BMC Genomics 2009, 10:190

http://www.biomedcentral.com/1471-2164/10/190

Figure
Real
Time
6 PCR gene expression analysis
Real Time PCR gene expression analysis. Validation of gene expression patterns from the microarray analysis (black
bars) by relative quantification through Real time PCR (open bars). A. Validation of gene expression patterns of PLAC8. B. Validation of gene expression patterns of HSPA1. C. Validation of gene expression patterns of HMGN3. D. Validation of gene
expression patterns of DNMT3a. E. Validation of gene expression patterns of DNMT3b. F. Validation of gene expression patterns of IGF2R.
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Figure
Real
Time
7 PCR gene expression analysis.
Real Time PCR gene expression analysis. Validation of gene expression patterns from the microarray analysis (black
bars) by relative quantification through Real time PCR (open bars). A. Validation of gene expression patterns of BIT1. B. Validation of gene expression patterns of NGDN. C. Validation of gene expression patterns of FBXO9. D. Validation of gene expression patterns of GNAI2. E. Validation of gene expression patterns of PGR. Real time PCR units indicate relative expression to
the internal standard GAPDH. Different letters on top of each bar indicate significant differences in expression (P < 0.01).
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Figure
Real
Time
8 PCR gene expression analysis in bovine donor cells.
Real Time PCR gene expression analysis in bovine donor cells. Gene expression analysis of PALLD, NFYA, GATM and
Taspase1 in donor cells lines derived from 0 rounds of cloning (DC0) first round of cloning (DC1), second round of cloning
(DC2), fourth round of cloning (DC4), and fifth round of cloning (DC5). Units indicate relative expression to the internal
standards GAPDH and 18S rRNA. Different letters indicate significant differences in expression between different donor cell
lines (P < 0.01).

RNA Isolation
RNA was isolated from IVF blastocysts, SCCT blastocysts,
and donor cells using the RNeasy MicroKit (Qiagen Valencia, CA) according to the manufacturer's specifications.
Briefly, embryos and cells frozen at -80°C in lysis buffer
were transferred to silica-gel membrane spin columns and
washed with RW1 wash buffer and 80% ethanol. Final
RNA elution was conducted using 14 l of RNAse free
water provided in the kit. Concentration and purity of isolated RNA were determined using a NanoDrop® ND-1000
Spectrophotometer (NanoDrop Technologies, Wilmington, DE). Integrity and quality were analyzed using a Bioanalyzer 2100 RNA 6000 Picochip kit (Agilent
Technologies, Palo Alto, CA).
Microarray
Microarray hybridizations were performed in triplicate for
each of the experimental groups using Affymetrix Bovine
DNA Chips as described by the manufacturer (Affymetrix
Santa Clara, CA). Briefly, complementary DNA (cDNA)
synthesis was performed from 10 ng total RNA using the
Two-Cycle cDNA Synthesis Kit (Affymetrix Santa Clara,
CA). The MEGAscript® T7 Kit (Ambion, Inc.) was used for
the first in vitro transcription (IVT). GeneChip IVT Labeling Kit was used for the second IVT and labelling of RNA.
Complementary RNA (cRNA) was fragmented and 10 g
of fragmented cRNA were hybridized to the Genechips in
a Hybridization Oven, set to 45°C and rotations of 60
rpm for 16 hours. The chips were then washed and stained

with streptavidin/phycoerythrin (SAPE) antibody solution using an Affymetrix FS-450 fluidics station. GeneChips were scanned using the Affymetrix GeneChip
scanner 3300.
Microarray data processing
Images were processed with the Affymetrix GeneChip®
Operating Software (GCOS) and expression quantified
with MAS 5.0, which also provides information on signal,
detection and calculated the detection p-value. Signal
information is a numeric value indicating transcript abundance for a particular probe set. Detection information
indicates whether the transcript is detected (P, present),
undetected (A, absent), or if it is at the limit of detection
(M, marginal). Detection p-value indicates the significance of the detection call for a probe set. Only probe sets
that were called Present in at least one of the five groups
were included in the analysis. A total of 5,599 probe sets
were excluded from the analysis as they were called Absent
in all groups. The data set for further analysis included
18,396 probe sets.
Hybridization quality check
Metrics like noise, background, Scale factor, and the ratio
of intensities of 3' probes to 5' probes for Actin and
GAPDH genes were analyzed for chip quality control.
Information about the intensities of the spiked in controls
(B. subtilis genes lys, phe, thr, and dap), which were mixed
with the total RNA at known concentrations at the begin-
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Figure of
Display
9 genes with high expression in IVF embryos
Display of genes with high expression in IVF embryos. Data modelling of genes with high expression in IVF embryos
compared to cloned embryos. The top networks in the pathway include cellular growth and proliferation, embryonic development, cellular assembly and organization, cellular death and response to stress and cancer.
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Display
10genes with high expression in CT embryos
Display of genes with high expression in CT embryos. Data modelling of genes with higher expression in CT embryos
compared to IVF embryos. The top networks in the pathway include cellular morphology, cellular development, cell signalling
and metabolism.
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ning of the experiment was used to monitor the linear
amplification and labelling process independently from
the target samples. The performance of the hybridization
control genes (E. coli genes BioB, BioC and BioD and P1
Bacteriophage cre) was also used for determining the quality of each chip.

uploaded in the Ingenuity Pathway Analysis 5.0. Since
Ingenuity Pathway Analysis database is based on human,
mouse, and rat genes, some of the bovine names were not
recognized by the software, mostly because of different
gene symbols. For those genes, we manually identified the
human orthologous symbol.

Microarray data analysis
For data visualization, the raw GeneChip signals were
uploaded into GeneTraffic UNO (Iobion Informatics
LLC), which generated scatter plots of pairwise hybridization comparisons and Heat maps from all hybridizations
using hierarchical clustering. Power Atlas, a web-based
resource from the University of Alabama at Birmingham,
was used to estimating the power of the hybridization
given the sample size [46]. HDBStat was used for statistical analysis[47]. Data were quantile-quantile normalized
and examined for outliers using Person's correlation.
Quality control statistics included a deleted residuals
approach [37,47,48]. False discovery rates (FDR) for the
genes were calculated using t-test [49]. Fold changes were
calculated based upon the unadjusted data means in pairwise comparisons. Probe sets in each pairwise comparison
with a p < 0.01, and FDR of <20%, and a Fold Change
(FC) in excess of 2.0 were considered to be significant and
examined further. For multiple comparisons, One-way
analysis of variance (ANOVA) from PROC GLM in SAS 9.1
(SAS Institute inc. Carey, NC) was performed on the complete data set. The Least Significant Difference (LSD) test
was used to detect significant differences between groups.
Annotation
The probe sets corresponding to differentially expressed
genes were uploaded into the Affymetrix Netaffx Analysis
Center (Bovine GeneChip annotation from November 6
2007) to retrieve updated information regarding gene
symbol, gene title, Biological Process (BP), Molecular
function (MF), and Cellular Component (CC) [50]. To
complement the annotation from Netaffx, we used the
GOAnna tool [51] from AgBase, a Mississippi State University curated, web-accessible resource for functional
analysis of agricultural plant and animal gene products.
For data visualization, all the GO terms associated to each
gene were uploaded into GOSlimViewer [52] another
AgBase tool that provides a high level summary of the GO
categories found in the dataset allowing a better visualization of the data.

Real time RT-PCR gene expression analysis
DNA microarray derived gene expression results for genes
DNMT3A, DNMT3B, IGF2R, PLAC8, PGR, BIT1, HMGN3,
HSPA1A, NGDN, FBXO9, and GNAI2 were confirmed by
Real time PCR using GAPDH as the reference gene. Complementary DNA was generated with the First-Strand
cDNA Synthesis system for RT-PCR using SuperScript III
Platinum® Two-Step qRT-PCR Kit (Invitrogen Life Technologies, Carlsbad, CA) according to the manufacturer's
protocol. The samples were incubated for 10 min at 25°C,
50 min at 42°C and at 85°C for 5 min. Then 2 U of E. coli
Rnase H was added to each tube and incubated at 37°C
for 20 min. The cDNA was used for quantitative real-time
PCR amplification with SYBR Green I chemistry (Roche
Applied Sciences, Indianapolis, IN). Real-time quantitative PCR was performed using the LightCyclerTM instrument (Roche Applied Sciences, Indianapolis, IN). The real
time PCR reactions were carried out in a total volume of
10 l according to the manufacturer's manuals for DNA
Master SYBR Green I mix (Roche Applied Sciences, IN).
The primer concentrations were adjusted to 0.5 M for
each gene. Primers were designed using Primer Premier 5
software (Premier Biosoft International, Palo Alto, CA).
Primer sequences used for real time PCR are shown in
Table 1. The cycling parameters were 30 seconds at 95°C
for denaturation, 50 cycles of 2 seconds at 95°C, 10 seconds at 55°C for amplification (quantification was performed at this step), and 12 seconds at 72°C for
extension. The specificity of all individual amplification
reactions was confirmed by melting curve analysis. Realtime expression values were calculated through the relative standard curve method, using 10-fold serial dilutions
for both the target and the endogenous reference genes by
measuring the cycle number at which exponential amplification occurred in a dilution series of samples. Values
were normalized to the relative amounts of the control
mRNA, which were obtained from a similar standard
curve. In real time PCR reactions, the same initial
amounts of target molecules were used, and the Cp values
of control mRNA were constant in all samples.

Data modelling
Ingenuity Pathway Analysis 5.0 from Ingenuity Systems
was used for data modelling and the analysis of networks
related to the generated data sets. Genes upregulated in
IVF embryos compared to CT embryos and donor cells
(Figure 8) and genes downregulated in IVF embryos compared to CT embryos and donor cells (Figure 9) were

Real time RT-PCR gene expression analysis from bovine
fetal donor cells
Donor cell lines included in the study were fibroblasts
from non-cloned foetuses (DC0), and fetal fibroblasts
from first, second, fourth, and fifth rounds of cloning
(DC1, DC2, DC4, and DC5). RNA isolation from donor
cells and subsequent cDNA synthesis were performed
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according to the above mentioned protocols. Relative
mRNA abundance was determined for paladin (PALLD),
nuclear transcription factor Y alpha (NFYA), glycine amidinotransferase (GATM) and Taspase 1 (C20orf13). Quantitative assessment of RNA amplification was detected by
SYBR® GreenER™ qPCR SuperMixes for iCycler (Invitrogen
Life Technologies, Carlsbad, CA, 11761-100). Real-time
PCR reactions were performed using the iCycler iQ RealTime PCR instrument (BIO-RAD). The cycling parameters
were 50°C for 2 min, 95°C for 8 min 30 s for denaturation, 40 cycles of 15 s at 95°C and 30 s at 60°C and 30 s
at 72°C for amplification and extension respectively. The
melting curve was performed starting at 55°C with a
0.5°C increase for 10 s in 80 cycles. Expression values
were calculated using the relative standard curve method.
Standard curves were generated using 10-fold serial dilutions for both GAPDH and 18S ribosomal RNA. Standard
curves were also generated for all target genes by measuring the cycle number at which exponential amplification
occurred.
Statistical analysis of Real Time PCR results
Results from different groups were analyzed by one-way
analysis of variance (ANOVA) by SAS 9.1 (SAS Institute
inc. Carey, NC). Differences at p < 0.001 were considered
significant. An additional analysis was performed using
Relative expression software tool (REST©, 384-beta version May 2005) to compare all samples of each group. The
mathematical model used in the REST software is based
on the PCR efficiencies (E) and the crossing point deviation between the samples (CP) [53-55].
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